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In this narrative review we focus on acute symptomatic seizures occurring in subjects with 
electrolyte disturbances. Quite surprisingly, despite its clinical relevance, this issue has received 
very little attention in the scientific literature. Electrolyte abnormalities are commonly encoun-
tered in clinical daily practice, and their diagnosis relies on routine laboratory findings. Acute 
and severe electrolyte imbalances can manifest with seizures, which may be the sole present-
ing symptom. Seizures are more frequently observed in patients with sodium disorders (es-
pecially hyponatremia), hypocalcemia, and hypomagnesemia. They do not entail a diagnosis 
of epilepsy, but are classified as acute symptomatic seizures. EEG has little specificity in dif-
ferentiating between various electrolyte disturbances. The prominent EEG feature is slowing 
of the normal background activity, although other EEG findings, including various epilepti-
form abnormalities may occur. An accurate and prompt diagnosis should be established for a 
successful management of seizures, as rapid identification and correction of the underlying 
electrolyte disturbance (rather than an antiepileptic treatment) are of crucial importance in 
the control of seizures and prevention of permanent brain damage.
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Acute Symptomatic Seizures Caused  
by Electrolyte Disturbances
INTRODUCTION
Electrolyte abnormalities are commonly encountered in clinical daily practice, and their 
diagnosis relies on routine laboratory findings. Electrolyte disturbances may affect the 
brain among many other organs and tissues and need to be promptly recognized as they 
may lead to severe and life-threatening complications when overlooked or not appropri-
ately treated. The neurological manifestations reflect the severity of acute neuronal de-
rangement and therefore require emergency treatment.1-3 Acute and/or severe electrolyte 
imbalances can manifest with rapidly progressive neurologic symptoms or seizures, which 
may be the sole presenting symptom. Seizures are more frequently observed in patients 
with sodium disorders (especially hyponatremia), hypocalcemia, and hypomagnesaemia.3 
Table 1 shows the different degrees of the electrolyte disturbances discussed in this review. 
An accurate and prompt diagnosis should be established for successful management of sei-
zures, as rapid identification and correction of the underlying electrolyte disturbance are of 
crucial importance in the control of seizures and prevention of permanent brain damage.2-4
In this narrative review we focus on acute epileptic seizures occurring in subjects with 
electrolyte disturbances. Quite surprisingly, despite its clinical relevance, this issue has re-
ceived very little attention in the scientific literature, with only a very few reviews specifical-
ly dealing with electrolytes disturbances and seizures published so far.3,4 
To conduct this review we selected the most relevant data from the available literature on 
this topic identified by searching PubMed using the search terms “seizures” or “epilepsy” 
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combined with “electrolyte”, “hyponatremia”, “hypernatre-
mia”, “hypocalcemia”, “hypercalcemia”, “hypomagnesemia”, 
“hypokalemia”, and “hyperkalemia”. Publications were cho-
sen based on the quality of data and their relevance to the 
present review. 
After an initial overview of this topic, which serves as gen-
eral introduction, we discuss the risk of seizures according to 
each type of electrolyte disturbance. 
A GENERAL OVERVIEW
The orderly function of the nervous system depends on its 
electrical excitability, which is maintained through a voltage 
gradient across neuronal and glial membranes by means of 
metabolically driven ion pumps. Alterations of electrolyte 
gradients across cellular membranes exert both direct and 
indirect effects on neuronal excitability and synchronization, 
and the consequent abnormal neuronal discharge may facili-
tate epileptiform activities.5 Specifically, there are several clini-
cal conditions, such as dehydration or renal failure, which 
can be associated with substantial modifications of plasma 
osmolality and electrolyte balance, determining marked al-
terations in brain metabolism and function leading to in-
creased risk of seizures.
In a recent proposal by the International League Against 
Epilepsy (ILAE) acute seizures were defined as “a clinical sei-
zure occurring at the time of a systemic insult or in close tem-
poral association with a documented brain insult.”6 Sugges-
tions were made to specify the brain insult as “events occurring 
within 1 week of stroke, traumatic brain injury, anoxic en-
cephalopathy, or intracranial surgery; at first identification 
of subdural hematoma; at the presence of an active central 
nervous system (CNS) infection; or during an active phase of 
multiple sclerosis or other autoimmune diseases.” In addi-
tion the ILAE suggest to make a diagnosis diagnosis of an 
acute symptomatic seizure “in the presence of severe meta-
bolic derangements (documented within 24 h by specific 
biochemical or hematologic abnormalities), drug or alcohol 
intoxication and withdrawal, or exposure to well-defined epi-
leptogenic drugs.”6 
Since electrolyte disturbances are, at least in the early stag-
es, generally not associated with morphologic changes in CNS, 
the neurologic manifestations are typically reversible.2-4,7 
However, seizures and the electrolyte disturbance itself can 
lead to structural alterations, so that the underlying electro-
lyte disturbances should be recognized and treated before 
the brain tissue injury becomes permanent.
Disorders of sodium and osmolality can be responsible for 
an encephalopathy characterized by depression of neuronal 
activity, with confusion, headache, psychomotor slowing and 
lethargy as the major clinical manifestations, usually associ-
ated with signs of irritability. Hypercalcemia and hypermag-
nesemia may also produce both a neuronal depression with 
encephalopathy and neuronal irritability. Hypocalcemia and 
hypomagnesemia lead almost exclusively to CNS irritability 
clinically manifesting with seizures, whereas disorders of po-
tassium rarely produce symptoms in the CNS, with muscle 
weakness being their major clinical manifestation.2,3,7
The main causes of electrolyte disturbances leading to 
acute seizures are reported in Table 2. 
Seizures occurring in patients with sodium disorders, hy-
pocalcemia, and hypomagnesemia,2,3,7 are usually general-
ized tonic-clonic, but also focal (partial) seizures or other 
seizure types may be present. Rapidly evolving electrolyte 
disturbances are more likely to cause seizures than those de-
veloping more gradually. It is therefore difficult to define ab-
solute levels of electrolyte above or below which seizures are 
likely to occur.3,7 
To identify the electrolyte disturbances leading to seizures, 
a complete serum chemistry evaluation, including measure-
ments of sodium, calcium, and magnesium should be per-
formed, in particular in subjects with a first-time seizures.3,8,9 
Since between 15 and 30% of acute symptomatic seizures 
among elderly patients occur in the setting of toxic-meta-
bolic causes,10 this diagnostic workup is particularly impor-
tant in the elderly. 
In a review of 375 adult cases of status epilepticus, 10% 
had a metabolic disorder as the primary etiology and mor-
tality in this subset of patients was as high as 40%.11 
Acute seizures due to electrolyte disorders may occur at 
any age, including infancy. When evaluating a first nonfe-
brile seizure occurring in children, the American Academy 
of Neurology has recommended that laboratory screening 
tests should be ordered based on individual clinical circum-
Table 1. Different degrees of the electrolyte disturbances that most frequently cause seizures
Electrolyte disturbance Mild Moderate Severe
Hyponatremia 130–134 mEq/L 125–129 mEq/L <125 mEq/L
Hypernatremia 145–149 mEq/L 150–169 mEq/L ≥170 mEq/L
Hypocalcemia 1.9–2.2 mEq/L <1.9 mEq/L
Hypercalcemia 2.5–3 mEq/L 3–3.5 mEq/L 3.5–4 mEq/L
Hypomgnesemia 0.8–1.6 mEq/L <0.8 mEq/L
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stances.12 More specifically, an electrolyte disturbance should 
be suspected (and laboratory tests ordered) in presence of 
vomiting, diarrhea, dehydration, or whenever the child has 
not returned to baseline alertness.12 Despite these recom-
mendations, the epidemiological data show that electrolyte 
disturbances (especially hyponatremia) represent a frequent 
cause of acute symptomatic nonfebrile seizures in patients 
of any age.1-5 Consequently, we think that these relatively in-
expensive and widely available laboratory tests should be sys-
tematically ordered in each patient presenting with a first 
Table 2. Main causes of electrolyte disturbances
Electrolyte disturbances Main causes
Hyponatremia Depletion of circulating volume
Congestive heart failure
Cirrhosis
Diarrhea
Disorders leading to increased antidiuretic hormone (ADH) levels
Syndrome of inappropriate ADH secretion
Adrenal insufficiency
Hypothyroidism
Pregnancy
Recent surgery
Excessive water intake
Polydipsia
Drugs 
Thiazide diuretics, desmopressin, mannitol, sorbitol, glycine, carbamazepine, oxcarbazepine, eslicarbazepine
Hypernatremia Excessive water loss
Impairment in access to water (infants, elderly)
Diarrhea
Central of nephrogenic diabetes insipidus
Drugs (mannitol)
Overload of sodium
Hypertonic sodium solutions
Water moving into cells
Convulsive seizures
Severe physical exercise
Hypocalcemia Hypoparathyroidism
Post-surgical (thyroidectomy, parathyroidectomy)
Idiopathic
Secondary hyperparathyroidism in response to hypocalcemia (renal failure)
Drugs
Bisphosphonates
Calcitonin
Severe vitamin D deficiency
Insufficient calcium intake (malnutrition)
Infants of mothers with vitamin D deficiency
Hypercalcemia Malignancy
Drugs
Thiazide diuretics
Vitamin D intoxication
Lithium
Primary hyperparathyroidism
Hypomagnesemia Loss of magnesium
Diarrhea
Abuse of laxatives
Drugs (loop and thiazide diuretics, cyclosporines, aminoglycoside antibiotics)
24  J Clin Neurol 2016;12(1):21-33
Electrolyte Disturbance and SeizuresJCN
acute seizure. 
Electrolyte disturbances may cause diffuse brain dysfunc-
tion that can be assessed by means of EEG recording. In gen-
eral, the most prominent feature of the EEG record in meta-
bolic encephalopathies is a slowing of the normal background 
frequency. If serial EEGs are performed, a gradually progres-
sive disorganization of the EEG recordings over the course 
of the disease can usually be noted. Moreover, reactivity to 
photic or other types of external stimulation is frequently al-
tered.13 EEG evolution generally correlates well with the se-
verity of encephalopathy; more specifically, the degree and 
severity of EEG abnormalities correlate with the rate of change 
of electrolyte balance rather than with the absolute level of 
a specific electrolyte or metabolite.14
However, EEG recordings have little specificity in differen-
tiating between the various etiologies of encephalopathy. In 
fact, in metabolic encephalopathies, EEG patterns are usu-
ally unspecific, including various degrees of diffuse slowing, 
epileptiform discharges, intermittent rhythmic slow activi-
ty, and occurrence of triphasic waves, which are usually re-
versible after treatment of the underlying causes.13,15
     
HYPONATRIEMIA
Hyponatremia is defined as a serum sodium level of less than 
135 mEq/L and is considered severe when the serum level 
is below 125 mEq/L. 
Clinical features
The clinical manifestations of hypotonic hyponatremia are 
largely related to CNS dysfunction and are more conspicu-
ous when the decrease in serum sodium concentrations is 
severe or occurs rapidly (within hours). The major clinical 
complications from acute hyponatremia are brain cell swell-
ing and herniation with neurologic symptoms being evident 
when hyponatremia approaches 120 mEq/L. The risk of ce-
rebral edema and neurologic manifestations is minimized if 
the decline in serum sodium occurs slowly and gradually (≥48 
h), even in case of a marked absolute reduction of serum so-
dium values. Conversely, in case of a rapid decrease in serum 
sodium (acute hyponatremia), cerebral edema with neuro-
logic symptoms are likely to occur.16,17
The neurological symptoms of hyponatremia therefore go 
in parallel with the severity of cerebral edema, and are less 
frequently induced by chronic than by acute hyponatremia: 
approximately half of the patients with chronic hyponatre-
mia are asymptomatic, even with serum sodium concentra-
tion less than 125 mEq/L.16,17 Symptoms in these patients 
rarely occur until the serum sodium is less than 120 mEq/L 
and are more usually associated with values around 110 mEq/L 
or lower.3 Particularly the children are at high risk of devel-
oping symptomatic hyponatremia, because of their larger 
brain-to-skull size ratio. Severe and rapidly evolving hypo-
natremia may cause seizures, which are usually generalized 
tonic-clonic, and generally occur if the plasma sodium con-
centration rapidly decreases to <115 mEq/L. 
Age and gender of the patient as well as other several fac-
tors influence the clinical outcome of neurological compli-
cations of hyponatremia. Children and women in childbear-
ing age (rather than postmenopausal women) are the most 
susceptible subjects:18,19 in a retrospective study hyponatre-
mia was the only detectable cause of seizures in 70% of in-
fants younger than 6 months.19 
Women seem to be particularly prone to develop postop-
erative hyponatremia.20 A case control study conducted in 65 
adults with postoperative hyponatremic encephalopathy and 
674 adult patients who had postoperative hyponatremia 
without encephalopathy showed a similar risk of developing 
hyponatremia and hyponatremic encephalopathy after sur-
gery in women and men. Surprisingly, women in childbear-
ing age had a 25-fold increased risk of death or permanent 
neurologic damage compared with either men or postmeno-
pausal females.20 Consequently, it is advisable to maintain a 
low threshold for hyponatremia and hyponatremic encepha-
lopathy in the event of headache, vomiting, nausea or lethar-
gy occurring after surgery, especially in women in childbear-
ing age.20 
Hyponatremia represents a frequent cause of epileptic sei-
zures, as shown in a recent prospective observational multi-
center study where acute epileptic seizures and focal neuro-
logical deficits were identified in 5% of patients with severe 
(<125 mEq/L) hyponatremia.21
Several etiologies may lead to hyponatremia, some of them 
affecting almost exclusively adults and some mostly children 
and infants. 
In adults, generalized seizures have been reported as the 
first manifestation of multihormonal pituitary hormone de-
ficiency causing normovolemic hyponatremia.22
Administration of some drugs, such as desmopressin23,24 or 
thiazide diuretics,25 may also lead to hyponatremia and sei-
zures. To date, 54 cases of hyponatremia secondary to des-
mopressin treatment for enuresis presenting with altered 
mental status or seizures have been reported. In 47 of them 
an intranasal formulation had been used, while excess fluid 
intake was documented as a contributing factor in at least 
22 cases. In most cases the neurological complications devel-
oped 14 days or less after starting desmopressin.24
Thiazide diuretics may cause hyponatremia in up to 14% 
of patients receiving these drugs (more commonly females, 
elderly subjects and subjects of low body weight), and may 
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cause confusion, falls and seizures.25 
Although also tricyclic antidepressants cause frequently 
hyponatremia, seizures associated with hyponatremia are 
more frequently observed in subjects taking selective sero-
tonin reuptake inhibitors.26-28
Several clinical conditions including fever (with true vol-
ume depletion) or polydipsia may also lead to hyponatremia. 
A study assessed the impact of fever on sodium values in 
children presenting with seizures during a gastroenteritis ep-
isode.29 While the presence or absence of fever did not affect 
seizure characteristics or duration, mild hyponatremia (so-
dium levels between 126 mEq/L and 134 mEq/L) was found 
to affect some seizure features, particularly seizure duration, 
with increased risk of status epilepticus. In fact, children 
with hyponatremia had more prolonged seizures than pa-
tients with normal serum sodium levels (6.4 minutes vs. 1.9 
minutes, respectively), irrespective of body temperature. In 
most cases, the seizures last less than 3 minutes (range: sev-
eral seconds to 20 minutes). 
Polydipsia, commonly seen in patients with psychiatric dis-
turbances, is another cause of hyponatremia with increased 
risk of seizures. A retrospective cross-sectional study was car-
ried out to study the association between different levels of 
hyponatremia and the occurrence of epileptic seizures in pa-
tients without a prior epilepsy diagnosis.30 The authors iden-
tified from the database of a Swedish County hospital 363 
in patients who were had serum sodium levels <125 mEq/L. 
Medical records were reviewed and 11 patients with seizures 
secondary to hyponatremia were identified. Seizures were 
the only neurologic manifestation of hyponatremia in the 
subjects with serum sodium levels >115 mEq/L. Marked in-
creases in the frequency of their complex partial seizures due 
to hyponatremia was observed in five patients with epilepsy 
and polydipsia-hyponatremia with a decrease in the serum 
sodium level to 118–127 mEq/L.31 In all cases, patients had 
received antipsychotic drugs, and the serum sodium levels 
returned to normal through restriction of fluids with conse-
quent decrease in seizure frequency. As this study shows, hy-
ponatremia caused by polydipsia is a risk factor for aggrava-
tion of habitual seizures in patients with epilepsy and psychiatric 
disorders. 
Other conditions reported to be associated with hypona-
tremia and seizures are the ingestion of sodium phosphate 
or sodium picosulfates/magnesium citrate combination, 
which are commonly used to evacuate the colon and rectum 
before colonoscopy or colorectal surgery,32 or polyethylene 
glycol preparation.33
Children and especially infants are particularly at risk of 
developing hyponatremia. A retrospective review reported 
130 infants with hyponatremia (<136 mEq/L) associated with 
respiratory syncytial virus bronchiolitis in infants requiring 
intensive care. Four infants (4%) had seizures at admission 
(sodium 114–123 mEq/L), and were successfully managed 
with hypertonic saline infusions followed by fluid restric-
tion, resulting in immediate termination of seizure activity 
and normalization of serum sodium values over 48 hours.34 
Two infants had water intoxication associated with hypo-
natremic seizures (sodium levels 116 mEq/L and 121 mEq/L) 
after consumption of commercial bottled drinking water for 
infants.35 
Hyponatremia should therefore be suspected in any in-
fant less than 6 months old presenting with acute seizures 
and a body temperature of ≤36.5 degrees C.36 In these pa-
tients, hyponatremia needs to be promptly recognized and 
treated to avoid complications, although improvement in 
neurologic function after correction of hyponatremia is usu-
ally more rapid in children than elderly patients.37
Although the American Academy of Neurology recom-
mends that laboratory screening tests for electrolytes should 
be ordered based on individual clinical circumstances such 
as vomiting, diarrhea or dehydratation,12 the epidemiological 
data show that hyponatremia is a frequent cause of acute 
symptomatic nonfebrile seizures in children. Consequently, 
laboratory tests should be systematically ordered in each child 
presenting with acute seizures. 
Finally, it is noteworthy to mention that the antiepileptic 
drugs (AED) carbamazepine (CBZ), oxcarbazepine (OXC), 
and eslicarbazepine (ESL) may themselves represent a cause 
of hyponatremia due to syndrome of inappropriate antidi-
uretic hormone.37 Possible mechanisms for this effect are an 
altered sensitivity to serum osmolality by the hypothalamic 
osmoreceptors and an increased sensitivity of the renal tu-
bules to antidiuretic hormone.37
AED-induced hyponatremia is usually asymptomatic, al-
though in some cases it may result in headache, confusion, 
general malaise, somnolence and in exacerbation of sei-
zures.38-41
CBZ, OXC, and ESL may lead to hyponatremia in a rele-
vant number of patients. One comparative study showed a 
much higher incidence of hyponatremia (defined as sodium 
levels ≤134 mEq/L) in patients treated with OXC compared 
to those receiving CBZ (29.9% vs. 13.5%; p<0.0001). Of note, 
sodium levels ≤128 mEq/L were found in 12.4% of patients 
treated with OXC and in 2.8% of those receiving CBZ (p< 
0.001).42 Hyponatremia during CBZ therapy seems to be 
particularly common in patients with intellectual disabili-
ty,43 which therefore should be considered a subset of sub-
jects particularly at risk. A subsequent study found an inci-
dence of severe (sodium levels ≤128 mEq/L) and symptomatic 
hyponatremia of 11.1% and 6.8%, respectively, in patients 
26  J Clin Neurol 2016;12(1):21-33
Electrolyte Disturbance and SeizuresJCN
treated with OXC.44 Age, AED polytherapy, and the concomi-
tant use of diuretics were found to be independent risk fac-
tors for sever hyponatremia following OXC treatment.44 Re-
cently, also ESL (the most recent AED structurally similar to 
CBZ to be marketed) has been shown to be associated with 
hyponatremia (sodium values ≤134 mEq/L) in 12.5% of pa-
tients affected by post-stroke seizures; in 10% of these pa-
tients, hyponatremia was symptomatic and in 3% it was as-
ymptomatic.45
The frequency of AED-induced hyponatremia is therefore 
particularly common after OXC administration, especially 
in the elderly or in patients taking diuretics. Incidence of hy-
ponatremia following OXC appears to be dose dependent 
(in one study an increase of 1 mg in the dosage of OXC was 
shown to increase the risk of hyponatremia by 0.2% and may 
be prevented by a slower and lower titration-initiation sched-
ule.46 Routine plasma sodium monitoring for patients re-
ceiving OXC is not usually necessary, except for patients re-
ceiving AED polytherapy or sodium depleting drugs (e.g., 
thiazide diuretics), affected by sodium-depleting disorders, 
or in the elderly.44,47 Conversely, monitoring of sodium serum 
levels are mandatory in patients under OXV therapy devel-
oping symptoms suggestive of hyponatremia (headache, 
confusion, general malaise, somnolence) and in those with 
unexplained worsening of seizures.46,47 Although no specific 
guidelines are available, these recommendations can be rea-
sonably extended to patients receiving CBZ, ESL and other 
sodium depleting drugs. 
EEG abnormalities
Hyponatremia usually produces nonspecific EEG slowing. 
A very severe hyponatremia may initially cause posterior 
slowing followed by diffuse delta activity. However, a vari-
ety of other EEG abnormalities have been described, such 
as triphasic waves, burst of high-voltage rhythmic delta ac-
tivity, and central high voltage 6-Hz to 7-Hz activity with 
stimulation-induced paroxysms of delta waves. Periodic lat-
eralized epileptiform discharges may also occur, while full 
seizure activity is very rare.13,48
A case of polydipsia-induced hyponatremia causing de 
novo nonconvulsive status epilepticus was associated with 
focal EEG discharges.49 After recovery from status epilepticus, 
EEG showed some spikes in the left frontal area. In this case 
it is reasonable to hypothesize that hyponatremia induced 
by polydipsia precipitated epileptogenicity in the left frontal 
area, and then focal activity secondarily generalized and led 
to status epilepticus. 
Treatment
Hyponatremic seizures represent an ominous sign and hence 
a medical emergency, as they are associated with high mor-
tality.2 Thus, a prompt recognition and treatment of acute 
symptomatic hyponatremia is of utmost importance as sec-
ondary brain damage may be rapid and irreversible, even in 
subjects with mild clinical symptoms.13 Since a small increase 
in the serum sodium concentration can substantially reduce 
cerebral edema, seizures induced by hyponatremia can be 
controlled by increasing the serum sodium concentration.14 
However, improvement in neurologic function may occur 
several days after correction of the electrolyte abnormality, 
particularly in elderly patients.50 
The most common treatment for hyponatremia consists 
of hypertonic saline (3%), which produces a rapid reduction 
in brain volume and intracranial pressure. An increase in 
serum sodium to values of 120 mEq/L to 125 mEq/L should 
be the target of therapy. Of note, more aggressive treatment 
of hyponatremia with hypertonic saline solution carries the 
risk of shrinkage of the brain leading to osmotic demyelin-
ation syndrome manifesting with severe neurologic symp-
toms such as quadriplegia, pseudobulbar palsy, coma, and 
even death.2,3,13 
The sodium concentration should therefore be corrected 
at a rate of 0.5 mEq/L/h. Higher correction rates (a rate of 1 
mEq/L to 2 mEq/L/h) have been used young patients at a 
risk for respiratory arrest, severe neurologic sequelae, and 
death14,51 and appear to be well tolerated in children.52
Hyponatremia induced by AED or other sodium-deplet-
ing drugs may be managed through water restriction, reduc-
tion of the dose and, if necessary, discontinuation.47 
HYPERNATREMIA
Hypernatremia is defined as a serum sodium concentration 
in plasma >145 mEq/L. 
Clinical features
While hyponatremia is often the cause of seizures or status 
epilepticus, hypernatremia is more likely to be the conse-
quence of convulsive seizure activity (especially generalized 
tonic-clonic seizures). In fact, during seizures intracellular 
glycogen is metabolized in the muscle to lactate. Since in-
tracellular osmolality of muscle fibers increases (lactate is 
more osmotically active than glycogen), water moves into 
cells, causing hypernatremia. A few minutes after the onset 
of hypernatremia, loss of water from brain cells determines 
an increased intracellular brain cell osmolality and shrink-
age of the brain.
The degree of CNS disturbance in hypernatremia is there-
fore related mainly to the rate at which the serum sodium in-
creases.53 In acute hypernatremia, the combination of hy-
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perosmolality and shrinkage in brain volume (especially in 
infants) results in an encephalopathy due altered synaptic 
structure and function of CNS cells.3,7 Conversely, in chron-
ic hypernatremic states, the risk of brain shrinkage with sub-
sequent neurological symptoms is minimized. A slow, grad-
ual increase in sodium values to levels as high as 170 mEq/L 
is often well tolerated. Severe symptoms of hypernatremia 
are primarily neurologic and usually result from an acute 
(i.e., within hours) elevation in the plasma sodium concen-
tration to >158–160 mEq/L. Values >180 mEq/L are associ-
ated with a high mortality rate, in adults more frequently 
than in children.53 In infants with hypernatremia seizures are 
typically absent, but can occur in case of inadvertent sodi-
um loading or aggressive rehydration.3,53
In patients with hypernatremia the rupture of cerebral veins, 
as well as the intracerebral and subarachnoid hemorrhages, 
which are induced by brain shrinkage, can in turn provoke 
seizures.3 Although rapid sodium loading can cause seizures, 
convulsions are more frequently seen during rapid correction 
of hypernatremia, and in ≤40% of patients treated for severe 
hypernatremia by rapid infusion of hypotonic solutions.3,6 
Treatment
The treatment of hypernatremia consists of replenishing body 
water, thus restoring osmotic homeostasis and cell volume 
at a rate that avoids significant complications. The speed of 
correction depends on the speed of development of hyper-
natremia and accompanying symptoms.53,54 In subjects with 
prolonged hypernatremia, cerebral edema may occur when 
the osmolality is abruptly normalized; this correction may 
therefore lead to convulsive seizures, coma, and death. The 
targeted correction of chronic hypernatremia should not ex-
ceed 0.5–0.7 mEq/L/h and 10 mEq/L/day to avoid compli-
cations. 
In subjects with acute hypernatremia the treatment may 
be more rapid, and a decrease in the serum sodium concen-
tration by 1 mEq/L/h can be considered appropriate.54
Patients with hypernatremia may be treated with hypoton-
ic fluids, such as hypotonic saline or dextrose solutions giv-
en orally or, if this approach is not feasible, intravenously. 
Importantly, the volume should be restricted to that re-
quired to correct hyperosmolality to prevent the risk of cere-
bral edema, which increases with the volume of the infusate.53 
HYPOCALCEMIA
Hypocalcemia is defined as a plasma calcium level of <8.5 mg/
dL or an ionized calcium concentration <4.0 mg/dL. 
Clinical features
The symptoms of hypocalcemia depend on the degree of hy-
pocalcemia and the speed of the decrease in the serum cal-
cium concentration.55 Acute hypocalcemia primarily causes 
increased neuromuscular excitability and tetany. 
The typical CNS manifestations of acute hypocalcemia are 
mental status changes and seizures.2,3,7 Generalized tonic-
clonic, focal motor, and (less frequently) atypical absence or 
even akinetic seizures may occur in patients with hypocal-
cemia even without muscular tetany.2,3,7 Hence, seizures can 
represent the unique presenting symptom of hypercalce-
mia.2,3,55 Nonconvulsive status epilepticus secondary to hy-
pocalcemia has also been reported.56 Seizures are a frequent 
complication of acute seizures: they have been reported in 
20–25% of patients with acute hypocalcemia, and in 30–70% 
of patients with idiopathic hypoparathyroidism.57,58
The main etiologies of hypocalcemia are hypoparathyroid-
ism, severe vitamin D deficiency (VDD) and drugs (Table 2).
Hypoparathyroidism, usually as a complication of thyroid-
ectomy, is a common cause of hypocalcemia. Characteristics 
of seizures at presentation, occurrence of subclinical seizures 
during follow-up, and the effect of AED withdrawal has re-
cently been assessed in 70 patients with IH.59 Seizures were 
present in 64% of patients (87% of them being generalized 
tonic-clonic), and were treated with phenytoin (47%), valpro-
ate (40%), and CBZ (27%). Most (69/70) patients were seizure-
free during the follow-up of 6.6±4.5 years. Ten of 14 (71.4%) 
patients were successfully withdrawn from AED and re-
mained seizure free during the follow-up period of 13.5±2.4 
months (range 9–18). In few patients AEDs were restarted 
because of the recurrence of seizures (n=3) and poor com-
pliance with calcium/vitamin D intake (n=1). The mean se-
rum total calcium increased from 1.9±0.19 to 2.1±0.14 mEq/L 
after AED withdrawal. 
Two cases with generalized tonic-clonic seizures as the 
first manifestation of postoperative hypoparathyroidism, ap-
pearing months and years after thyroidectomy have been de-
scribed.60 Thus, iatrogenic (i.e., postoperative) hypoparathy-
roidism needs to be considered in the differential diagnosis 
of adult-onset, generalized, tonic-clonic seizures even if the 
thyroidectomy was performed years earlier. 
Hypocalcemic seizures may also occur in subjects with 
severe VDD, frequently in children and during the neonatal 
period.61-64 Overall, seizures during the neonatal period have 
a broad differential diagnosis.61 Unlike in developing coun-
tries, where VDD and hypocalcemia constitutes a major 
cause of infantile seizures, the number of neonatal seizures 
attributed to hypocalcemia in developed countries has de-
creased dramatically due to the obligatory vitamin D supple-
mentation. In developed countries, most infants presenting 
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with hypocalcemic seizures have underlying endocrinologi-
cal etiologies rather than dietary insufficiencies.61,62
The incidence of hypocalcemic seizures secondary to 
VDD in children in the UK and Ireland have been investi-
gated in one study.62 Ninety one confirmed or probable cas-
es were reported, equating to an overall annual incidence of 
3.49 per million children aged 0–15 years. Incidence was sig-
nificantly greater in males compared to females, in infants 
compared to older children, and in children of South Asian 
or Black ethnicity compared to children from white ethnic 
backgrounds. The authors concluded that current imple-
mentation of public health policy in the UK is not success-
ful in preventing children from developing one of the severe 
manifestations of VDD. 
Severely-malnourished children presenting with hypocal-
caemia have an increased risk of death than those without 
hypocalcaemia.63 In this subset of patients, the prevalence 
of hypocalcaemia has been reported to be as high as 26%.62 
Acute diarrhea, convulsive seizures, and lethargy on admis-
sion to hospital are the main clinical predictors of hypocal-
cemia in these children. The presence of these features in 
hospitalized children with severe acute malnutrition should 
alert clinicians about the possibility of hypocalcemia and 
may help undertake potential preventive measures, in par-
ticular calcium supplementation. Also infants with rickets 
may be particularly prone to acute convulsive seizures due 
to hypocalcemia.64 
A possible link between acute neonatal seizures, hypocal-
cemia and subsequent severe intellectual disability has been 
assessed in 149 adults with 22q11.2 deletion syndrome.65 A 
history of neonatal seizures and neonatal hypocalcemia were 
significant predictors of a more severe level of intellectual 
disability, suggesting that neonatal seizures may increase the 
risk for more severe intellectual deficits in 22q11.2 deletion 
syndrome, likely mediated by neonatal hypocalcemia. 
A study conducted in UK among children presenting to 
the emergency department identified 89 patients with a low 
vitamin D level (total vitamin D levels less than 50 nmol/L), 
with 83% of those having very low vitamin D levels (less than 
25 nmol/L).66 Seizures were present in 17% of patients, whose 
most common ethnic origins were Pakistani (37%) and black 
African (11%). Thus, acute seizures following hypocalcemia 
due to severe VDD should be particularly suspected in chil-
dren from developing countries or with specific ethnic origins.
Furthermore, it is important to remind that maternal VDD 
is commonly observed in nursing mothers of infants diag-
nosed with rickets and that mothers of infants presenting 
with hypocalcemic seizures invariably have severe VDD.67,68 
Hypocalcemic seizures in infants secondary to maternal VDD 
might be prevented by supplementation of vitamin D.67
Although rarely, hypocalcemic seizures may also follow the 
administration of zoledronic acid, an aminobisphosphonate 
that is administered annually against osteoporosis.69 
Chvostek’s and Trousseau’s signs are two physical findings 
resulting from a neuromuscular hyperexcitability due to la-
tent tetany associated with reduced serum ionized calcium 
may provide clues to a diagnosis of hypocalcemia, although 
they have no value in differentiating among the various eti-
ologies leading to this electrolyte imbalance. Chvostek’s sign 
is a contraction of the ipsilateral facial muscles, ranging from 
minimal twitching of the lip to spasm of all muscles, elicited 
by tapping the facial nerve just anterior to the ear. Converse-
ly, Trousseau’s sign refers to the occurrence of a carpopedal 
spasm (i.e., adduction of the thumb, flexion of the wrist and 
metacarpophalangeal joints, and extension of the interpha-
langeal joints) following inflation of a sphygmomanometer 
above systolic blood pressure for three minutes. 
A study assessed the clinical utility of Chvostek’s sign in 
154 patients with seizures (epilepsy, n=91; non-epileptic event, 
n=41; febrile convulsion, n=19; hypocalcemic seizure, n=3).70 
While patients with febrile convulsions or non-epileptic sei-
zures had either negative or mild Chvostek’s sign, a marked 
Chvostek’s sign was only found among those with the diag-
nosis of epilepsy or hypocalcemia. Normocalcemic patients 
had no other signs of neuromuscular hyperexcitability while 
those with hypocalcemia manifested positive Trousseau’s sign 
and other signs of neuromuscular hyperexcitability. 
EEG abnormalities
Early EEG abnormalities associated with hypocalcemia in-
clude slowing of background rhythm with evolution from 
alpha through theta and diffuse increase in slow wave activ-
ity in the theta and delta range. Generalized spikes, sharp-
waves burst of delta activity with sharp components, have 
also been reported and associated with absence seizures.13 Neo-
natal EEG recordings may show reversible 3- to 4-Hz spike-
waves discharges.71 
Treatment
The indication for urgent therapy for hypercalcemia usually 
reflects the severity of neurological symptoms and the de-
gree of hypocalcemia. Acute hypocalcemia is an emergency 
that requires prompt attention, and patients with symptom-
atic hypocalcemia should be treated immediately because 
of the highly associated morbidity and mortality. Treatment 
with intravenous calcium is the most appropriate therapy. 
Doses of 100 mg to 300 mg of elemental calcium should be 
infused intravenously over a period of 10 min to 20 min. Cal-
cium-infusion drips should be started at 0.5 mg/kg/h and 
continued for several hours, with close monitoring of calci-
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um levels.55 Hypocalcemic seizures should be treated with 
calcium replacement, while AEDs are typically not needed. 
Interestingly, AEDs may abolish both overt and latent tetany, 
whereas hypocalcemic seizures may remain refractory.57,71,72 
Obviously, the treatment of hypocalcemia should be directed 
at the underlying disorder, and oral calcium repletion is com-
monly prescribed for outpatient treatment.
HYPERCALCEMIA
Hypercalcemia is defined as serum calcium levels of ≥2.5 
mmol/L. 
Clinical features
Hypercalcemia (especially that related to malignancy) is 
much more common than hypocalcemia,2,3,55 but is less fre-
quently associated with acute seizures. The most common 
symptoms of severe hypercalcemia (defined as calcium lev-
els higher than 3.5 mmol/L) are related to disturbances of 
nervous system and gastrointestinal function.2,3,60
A rapid increase to moderate (12–13.9 mg/dL) hypercal-
cemia frequently results in marked neurologic dysfunction. 
On the contrary, chronic severe hypercalcemia (≥14 mg/dL) 
usually causes only minimal neurologic symptoms.73
The main neurologic manifestations of hypercalcemia are 
drowsiness, lethargy, weakness, and confusion. Hypercalce-
mia is associated with reduced neuronal membrane excit-
ability, and thus only rarely causes seizures. However, hy-
percalcemia-induced hypertensive encephalopathy and 
vasoconstriction have been hypothesized to be responsible 
for seizures.3,14,74
EEG abnormalities
In subjects with hypercalcemia EEG abnormalities (fast ac-
tivity and burst of delta and theta slowing) appear when cal-
cium levels are higher than 13 mg/dL. At higher calcium 
levels, increased background slowing (mainly frontal), par-
oxysmal theta/delta bursts, and triphasic waves can be ob-
served.13,75 Diffuse and more occipital spike-slow-wave com-
plexes may also appear, possibly due to a calcium-mediated 
vasospasm in the posterior cerebral circulation, which can 
be noted with very high calcium levels.76 In most cases, nor-
malization of calcium levels improves, even if gradually, the 
EEG pattern. 
Treatment
The urgency of treatment depends on the presence of clini-
cal manifestations and the underlying cause of the problem, 
rather than on the serum calcium levels. Severe hypercalce-
mia should be treated aggressively with hydration and ad-
ministration of medications used to decrease calcium serum 
level such as intravenous bisphosphonate (e.g., pamidronate 
or zoledronate) or calcitonin.55 First, vigorous rehydration 
with normal saline should be initiated at a rate of 200 to 500 
mL/h, monitoring fluid overload. Then 20–40 mg furose-
mide may be administered intravenously, after rehydration 
has been achieved. If high calcium levels persist, the use of 
intravenous bisphosphonates (pamidronate or zoledronate), 
and in second line of glucocorticoids, calcitonin, mithramy-
cin, gallium nitrate, may be considered.
In subjects with chronic or asymptomatic hypercalcemia 
the management can be limited to treatment of the underly-
ing disorder with hypocalcemic diet, although oral bisphos-
phonates may also be administered.
HYPOMAGNESEMIA
Hypomagnesemia is defined as a plasma concentration of 
magnesium <1.6 mEq/L; magnesium values lower than 0.8 
mEq/L represent severe hypomagnesemia. 
Clinical features
Magnesium has membrane-stabilizing effects and interacts 
with N-methyl-D-aspartate glutamate receptors which, when 
activated, leads to a massive depolarization of neuronal net-
works and bursts of action potentials.77 Magnesium also acts 
as a voltage-dependent calcium channel antagonist and pre-
vents membrane depolarizations. Furthermore it leads to an 
increased production of vasodilatatory prostaglandins in 
the brain.78 Symptoms of hypomagnesemia usually occur at 
serum ionized Mg2+ levels lower than 1.2 mg/dL, although 
they do not always correlate with Mg2+ concentrations. The 
most important clinical features of hypomagnesemia are 
neuromuscular irritability, CNS hyperexcitability, and car-
diac arrhythmias. Seizures (usually generalized tonic-clonic) 
can occur in neonates and adults in association with severe 
hypomagnesemia, usually at levels <1 mEq/L.2 
HIV-seropositive patients and children are particularly 
prone to develop acute seizures and statu epilepticus follow-
ing hypomagnesemia, although the mechanisms leading to 
this propensity are unclear.79 Hence, all HIV-seropositive 
patients with new-onset seizures should undergo metabolic 
screening including renal function and serum magnesium 
levels.79
Also children (especially infants) may experience seizures 
following severe (magnesium levels <0.8 mEq/L) hypomag-
nesemia. In a pediatric study conducted in West Indies, 3% 
of children aged 6 months to 8 years presenting with fever 
and seizures to the emergency department had hypomag-
nesaemia.80 In these patients hypomagnesemia was consid-
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ered to be the cause of seizures, as meningitis or an underly-
ing bacterial infection were excluded, as well as hyponatremia, 
hypocalcaemia or hypoglycemia. 
Hypomagnesemia has recently been recognized as an im-
portant side effect of proton pump inhibitors (PPIs), and also 
several cases of hypomagnesemia-induced seizures in sub-
jects taking PPIs have been reported.81,82
Treatment
Mild (magnesium levels between 0.8 mEq/L and 1.6 mEq/L) 
and/or asymptomatic hypomagnesemia can be treated with 
oral administration of magnesium (e.g., magnesium gluco-
nate), usually given in divided doses (total daily dose of 500 
mg). Symptomatic or severe (<1.2 mg/dL, <1 mEq/L) hypo-
magnesemia, especially if seizures are present, requires an 
injection of 1 to 2 g of magnesium sulfate over a 5-min peri-
od, followed by an infusion of 1 to 2 g per hour for the next 
few hours, which may be repeated if seizures persist. In pa-
tients with renal insufficiency, these dosages should be re-
duced.2,83 During treatment potassium and magnesium levels 
should be closely monitored. In women with eclampsia/pre-
eclampsia, magnesium sulfate 4-g to 6-g loading dose diluted 
in 100 mL fluid should be given intravenously over 15 min-
utes, followed by continuous intravenous infusion at 1 to 2 g 
per hour, which can be discontinued 24 hours after delivery 
or last seizure.77,84 Intravenous magnesium has also been ad-
ministered in status epilepticus, even in the absence of evi-
dence of magnesium deficiency.85,86 The infusion should be 
given at doses that increase serum level from 0.81 mM to 3.5 
mM (loading dose and then continuous infusion).
POTASSIUM ABNORMALITIES
Unlike other electrolyte abnormalities, hypokalemia or hy-
perkalemia rarely cause symptoms in the CNS, and seizures 
do not occur. Changes in the extracellular potassium serum 
levels exert their effects mainly on the function of the cardio-
vascular and neuromuscular systems. Severe potassium ab-
normality may therefore provoke fatal arrhythmias or mus-
cle paralysis before CNS symptoms appear.2,3,86 
THE EPILEPTOLOGICAL  
POINT OF VIEW
Seizures occurring as a consequence of electrolyte imbalance 
do not entail a diagnosis of epilepsy, but are currently clas-
sified as acute symptomatic seizures. The key point and at 
the same time the clinical problem is to assign a seizure to a 
cause. According to Shorvon87 a causal relationship is pres-
ent when the following five criteria should be fulfilled.
1) Temporal association: The exposure to the risk factor, 
in this case electrolyte disturbance, should precede the de-
velopment of a seizure.
2) Strength of association: The greater the difference on 
patients with or without a certain electrolyte disturbance is, 
the more likely it is a true association.
3) Consistency: the association should be reducible.
4) Biological gradient: There should be evidence for a dose 
response.
5) Biological plausibility: The mechanisms of seizure gen-
eration should be related to the electrolyte abnormality.
With electrolyte disturbances and acute seizures the tem-
poral relationship is most often the clue to the diagnosis. For 
metabolic conditions with subsequent alterations of homeo-
stasis such as in the case of electrolyte imbalance, a diagno-
sis of acute symptomatic seizures should be made by taking 
into consideration specific cutoff values having high speci-
ficity in order to reduce the risk of false positive (i.e., the risk 
that the seizures were not caused by a metabolic derange-
ment).6 To classify a seizure as acute symptomatic due to 
metabolic condition, the proposed cutoffs and a temporal 
relationship of the seizure (usually less than 24 h) need to be 
met.6 The greatest problem in interpreting the studies on 
electrolyte disturbances and seizures is the criterion of a bio-
logical gradient. In acute electrolyte derangements there 
seems to be an association with the severity of symptoms, es-
pecially with hyponatremia, but in chronic forms severe ab-
normalities are tolerated without any clinical signs. To as-
sign a seizure in chronic electrolyte abnormality is sometimes 
impossible, and prudent clinical judgment is necessary to 
manage acute symptomatic seizures in electrolyte distur-
bance the patient appropriately. 
Unlike epilepsy which is defined as “a disorder character-
ized by an enduring predisposition to generate epileptic sei-
zures”,88 acute symptomatic seizures are not necessarily char-
acterized by such a tendency to recur,6,89 unless the underlying 
causal condition reoccurs. It is however of great importance 
to treat the underlying cause, as acute symptomatic seizures 
carry a higher early mortality, compared to unprovoked sei-
zures.89
As a consequence, most patients experiencing acute symp-
tomatic seizures may not need a prolonged antiepileptic 
treatment, although they necessarily require a simultaneous 
management aimed at resolving the underlying cause of the 
seizures.6,90 Obviously, when choosing an AED to treat acute 
symptomatic seizures, it is reasonable to prefer medications 
which are easily and rapidly administered and have no in-
fluence themselves on electrolyte balance as it is the case with 
CBZ, OXC or ESL acetate.90 
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CONCLUSION
Seizures represent an important clinical manifestation of elec-
trolyte disorders and are more frequently observed in pa-
tients with hyponatremia, hypocalcemia, and hypomagnese-
mia. In these subjects, the successful management of seizures 
begins with an accurate diagnosis of the underlying electro-
lyte disturbances. Complete serum chemistry, including so-
dium, calcium, and magnesium, should therefore be part of 
the initial diagnostic workup in patients with seizures. Early 
identification and correction of these disturbances are nec-
essary to control seizures and prevent permanent brain dam-
age, as AED alone are generally ineffective if the electrolyte 
disorder persists. In fact, treatment of seizures secondary to 
electrolyte imbalances is determined by the underlying cause 
of the disturbance, and in most cases administration of AED 
is not necessary as long as the underlying disturbance is rec-
tified.2-4,6 The physicians should therefore be aware of the ex-
istence of acute seizures due to electrolyte disturbances and 
have an understanding of the underlying medical conditions 
leading to electrolyte imbalance, for this may provide the 
means of controlling the disease and initiate a rapid and ap-
propriate therapy.
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